Search

Home > Head & Neck Cancer Update > Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
Podcast: Head & Neck Cancer Update
Episode:

Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
Category: Science & Medicine
Duration: 01:02:34
Publish Date: 2024-09-06 12:00:00
Description:

Prof Peter Schmid from the Barts Cancer Institute in London, United Kingdom, and Dr Sara Tolaney from the Dana-Farber Cancer Institute in Boston, Massachusetts, review clinical trials investigating the role of antibody-drug conjugate-mediated therapies in the treatment of metastatic breast cancer.

CME information and select publications here
Total Play: 0

Some more Podcasts by Research To Practice

200+ Episodes
Oncology Nur ..    
200+ Episodes
Visiting Pro ..    
100+ Episodes
Cancer Confe ..    
20+ Episodes
Patterns of ..